Isolation and characterization of temperature-sensitive mutants of Streptococcus suis: efficacy trial of the mutant vaccine in mice.
A model of experimental Streptococcus suis infection was developed in young mice. Minimum lethal dose (MLD) values were calculated for four virulent serotypes (1/2, 1, 2, 3) of S. suis using this model. Temperature-sensitive (ts) mutants of S. suis serotypes 1/2 and 1-8 were isolated and characterized on the basis of their growth kinetics and reversion rates. Ts mutants of S. suis 1/2, 1, 2, and 3 were tested as vaccines against the virulent homologous and heterologous challenges in mice. The protection provided was evaluated by analyzing the clinical signs, death or survival. Homologous but not heterologous protection was noted in all mice vaccinated with the mutant strains. Ts mutants of S. suis 1/2 provided 100% protection against challenge by virulent strains of S. suis 1/2, 1, and 2.
Kebede
M
M
Department of Biological Sciences, Murray State University, KY 42071.
Chengappa
M M
MM
Stuart
J G
JG
D000818:Animals; D001428:Bacterial Vaccines; D015169:Colony Count, Microbial; D004195:Disease Models, Animal; D007700:Kinetics; D051379:Mice; D009154:Mutation; D013290:Streptococcal Infections / Q000517:prevention & control / Q000662:veterinary*; D013291:Streptococcus / Q000235:genetics / Q000254:growth & development / Q000276:immunology*; D013552:Swine; D013553:Swine Diseases / Q000517:prevention & control*; D014611:Vaccination / Q000662:veterinary
D001428:Bacterial Vaccines